Canagliflozin Promotes Structural and Functional Changes in Proximal Tubular Cell Mitochondria of Hypertensive–Diabetic Mice
Mayra Trentin-Sonoda, Yan Burelle, Alex Gutsol, Robert L. Myette, Richard L. Hébert · 2025
Read Canagliflozin Promotes Structural and Functional Changes in Proximal Tubular Cell Mitochondria of Hypertensive–Diabetic Mice by Mayra Trentin-Sonoda, Yan Burelle, Alex Gutsol, Robert L. Myette, Richard L. Hébert (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732475.txt.
Description
Mayra Trentin-Sonoda and co-authors test a diabetes drug in mice with both high blood pressure and diabetes, in a 2025 study. The drug, canagliflozin, lowers blood sugar and is known to protect the kidneys. The team asked whether that protection extends to the mitochondria, the cell parts that make energy, in kidney tubule cells.
After one week on drug-laced food, treated male mice showed less protein in their urine, a sign of kidney strain. Their tubule cells had more linked, branched mitochondria, plus higher breathing rates and energy output. Female mice showed a milder response, with shape changes but no gain in energy measures. The authors link the drug's kidney benefit in part to this repair of cell energy systems.
Catalog record
| CREATOR | Mayra Trentin-Sonoda, Yan Burelle, Alex Gutsol, Robert L. Myette, Richard L. Hébert |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |